Skip to main content
. 2015 Apr 24;6(3):255–259. doi: 10.1111/1759-7714.12174

Table 5.

The comparison of short-term efficacy between primary and metastatic targets under different tracking methods

Primary targets CR PR SD ORR
Synchrony 11 (39.29%) 15 (53.57%) 2 (7.14%) 26 (92.86%)
Xsight spine 4 (30.77%) 7 (53.85%) 2 (15.38%) 11 (84.62%)
P-value X2 = 0.79, P = 0.67
Metastatic targets CR PR SD ORR
Synchrony 9 (52.94%) 7 (41.18%) 1 (5.88%) 16 (94.12%)
Xsight spine 2 (14.29%) 7 (50.00%) 5 (35.71%) 9 (64.29%)
P-value X2 = 6.90, P = 0.032